1. Home
  2. COHN vs PFSA Comparison

COHN vs PFSA Comparison

Compare COHN & PFSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COHN
  • PFSA
  • Stock Information
  • Founded
  • COHN 1999
  • PFSA 2009
  • Country
  • COHN United States
  • PFSA United States
  • Employees
  • COHN N/A
  • PFSA N/A
  • Industry
  • COHN Investment Bankers/Brokers/Service
  • PFSA Medical/Dental Instruments
  • Sector
  • COHN Finance
  • PFSA Health Care
  • Exchange
  • COHN Nasdaq
  • PFSA Nasdaq
  • Market Cap
  • COHN 21.6M
  • PFSA 25.1M
  • IPO Year
  • COHN N/A
  • PFSA N/A
  • Fundamental
  • Price
  • COHN $12.59
  • PFSA $0.50
  • Analyst Decision
  • COHN
  • PFSA
  • Analyst Count
  • COHN 0
  • PFSA 0
  • Target Price
  • COHN N/A
  • PFSA N/A
  • AVG Volume (30 Days)
  • COHN 11.4K
  • PFSA 7.9M
  • Earning Date
  • COHN 07-31-2025
  • PFSA 01-01-0001
  • Dividend Yield
  • COHN 7.94%
  • PFSA N/A
  • EPS Growth
  • COHN 37.63
  • PFSA N/A
  • EPS
  • COHN 1.14
  • PFSA N/A
  • Revenue
  • COHN $133,173,000.00
  • PFSA $75,000.00
  • Revenue This Year
  • COHN N/A
  • PFSA N/A
  • Revenue Next Year
  • COHN N/A
  • PFSA N/A
  • P/E Ratio
  • COHN $11.19
  • PFSA N/A
  • Revenue Growth
  • COHN 78.63
  • PFSA 150.00
  • 52 Week Low
  • COHN $6.10
  • PFSA $0.46
  • 52 Week High
  • COHN $13.25
  • PFSA $5.50
  • Technical
  • Relative Strength Index (RSI)
  • COHN 69.24
  • PFSA N/A
  • Support Level
  • COHN $11.02
  • PFSA N/A
  • Resistance Level
  • COHN $12.89
  • PFSA N/A
  • Average True Range (ATR)
  • COHN 0.66
  • PFSA 0.00
  • MACD
  • COHN 0.03
  • PFSA 0.00
  • Stochastic Oscillator
  • COHN 88.10
  • PFSA 0.00

About COHN Cohen & Company Inc.

Cohen & Co Inc is a United States company that delivers financial services in fixed-income markets. It is focused on small-cap banking institutions and has grown to provide an expanding range of capital markets and asset management services. It has three business segments. The Capital Markets segment, which is the key revenue driver, consists of fixed-income sales, trading, matched book repo financing, new issue placements in corporate and securitized products, and advisory services. The Asset Management segment manages assets within collateralized debt obligations, managed accounts, joint ventures, and investment funds. The Principal Investing segment is comprised of investments to earn return rather than to support trading, matched book repo, or other Capital Markets segment activities.

About PFSA Profusa Inc. Common Stock

Profusa Inc is a digital health technology company based in Emeryville, CA, that has developed a real-time, consumer-friendly platform that is designed to measure an individual's biochemistry, be easy to use, be cost-effective, and provide the necessary data to manage chronic disease and health and wellness decisions to improve health outcomes for a large population of potential users. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term.

Share on Social Networks: